Therefore, we conclude that TNK exerts its effects on the PI3K/AKT signaling pathway by downregulating SHIP2, thereby improving insulin resistance and exerting protective effects on podocyte injury in the DN mice and high glucose-stimulated MPC5 cells. This evidence concerns the gene AKT1 and liver dysplastic nodule.